---
document_datetime: 2023-09-21 19:00:04
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/sepioglin-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: sepioglin-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.0082085
conversion_datetime: 2025-12-19 01:23:11.369158
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
<!-- image -->

| Application number   | Scope                                                                                          | Opinion/ Notification 1 issued on no   | Commission Decision Issued 2 / amended   | Product Information affected   | Summary   |
|----------------------|------------------------------------------------------------------------------------------------|----------------------------------------|------------------------------------------|--------------------------------|-----------|
| IAIN/0001            | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation | 05/10/2012 product                     | on n/a                                   |                                |           |

<!-- image -->

<!-- image -->